Passage Bio, Inc. (PASG)

4.50 +0.07 (+1.58%) USD  |  NASDAQ  |  Sep 01, 09:58
More

Passage Bio Cash from Operations (Annual) : -31.51M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -31.51M
December 31, 2024 -47.96M
December 31, 2023 -78.26M
December 31, 2022 -118.21M
Date Value
December 31, 2021 -126.88M
December 31, 2020 -80.52M
December 31, 2019 -39.90M
December 31, 2018 -18.57M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. -170.87M
ACADIA Pharmaceuticals, Inc. 109.84M
Alnylam Pharmaceuticals, Inc. 524.08M
Anika Therapeutics, Inc. 11.19M
Savara, Inc. -101.04M